JAOA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


JAOA • Vol 103 • No 8_suppl_4 • August 2003 • 2-9
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenthal, M. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rosenthal, M. H.

Barriers to Diagnosis, Advances in Therapy

Murray H. Rosenthal, DO

Correspondence to Murray H. Rosenthal, DO, Medical Director and CEO, BMR HealthQuest, 3625 Ruffin Rd, Suite 100, San Diego, CA 92123-1841.E-mail: rosenthal{at}bmrhealthquest.com

Depression is underdiagnosed in primary care because of several factors, including variances in the clinical presentation of depressive symptoms, as well as comorbid medical, psychiatric, and substance abuse problems. Time constraints imposed by managed care add to the challenge of diagnosis. The current medical system encourages a reliance on somatic symptoms for accurate diagnosis, and tools that measure somatic symptoms, such as the Primary Care Rapid Assessment Scale, may be useful. After diagnosis, the depressed patient may benefit from one of the many new antidepressant modes of therapy and medications in the pipeline. Psychotherapeutic treatment modalities should also be taken into account. These diagnostic and therapeutic options are rapidly becoming available to primary care physicians, who should use them to achieve long-term remission of depressive symptoms.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Osteopathic Association.